Breast Cancer and Multiple Myeloma Time to First SREDeaths and Dropouts Considered SREs (010)

Median time, P-value  N (%)§ days vs Pam 90 mg

ZOMETAŽ 4 mg 561 (58) 312 .099

ZOMETA 8/4 mg 555 (59) 265 .545

Pam 90 mg 524 (61) 252

§Kaplan-Meier estimate of the proportion at Month 13.

Previous slide

Next slide

Back to first slide

View graphic version